 VANCOUVER, Wash., Feb. 17, 2022 GLOBE NEWSWIRE -- Absci Corporation Nasdaq: ABSI, the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the following investor conferences. 